ABSTRACT
Nineteen consecutive patients with clinically suspected sarcoidosis underwent 67Ga-scintigraphy prior to transbronchial lung biopsy (TBLB) to determine if 67Ga uptake in lung parenchyma would increase the diagnostic yield of the biopsy procedure. Biopsies were obtained from the areas showing parenchymal uptake on the 67Ga scan in 13 of the 19 patients. In the six patients not demonstrating uptake of 67Ga in the lung parenchyma, biopsies were obtained at random from the right lower lobe. There was no correlation between 67Ga uptake in hilar nodes or pulmonary parenchyma tissue and the diagnostic yield from TBLB. We conclude that 67Ga scanning is neither efficacious nor cost-effective in predicting the diagnostic yield of TBLB in sarcoidosis.
Subject(s)
Gallium Radioisotopes , Lung Diseases/diagnostic imaging , Sarcoidosis/diagnostic imaging , Biopsy, Needle , False Negative Reactions , False Positive Reactions , Humans , Lung Diseases/pathology , Radionuclide Imaging , Sarcoidosis/pathologyABSTRACT
Fiberoptic bronchoscopy is employed extensively in the examination of patients with pulmonary disease. As demonstrated in this large series, the procedure can be performed safely and efficiently on an outpatient basis, with the use of only topical anesthesia. Discomfort is minimal and readily accepted by most patients. Bronchial biopsies of suspected neoplastic lesions can be performed without difficulty. Outpatient bronchoscopy in an appropriate clinical setting can hasten the medical evaluation without compromising patient care.
